Loading companies…
Loading companies…
South Korea · Biotech · AI
Develops AI-driven protein design platform for de novo antibody and drug discovery
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $29M | DAYLI Partners — Role not disclosedInterVest — Role not disclosedKorea Development Bank (KDB) — Role not disclosedKorea Investment & Securities — Role not disclosedMirae Asset Securities — Role not disclosedNCORE Ventures — Role not disclosedPathway Investment — Role not disclosedSL Investment — Role not disclosedSneakPeek Investments — Role not disclosedYuanta Investment — Role not disclosed |